Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5284532
Max Phase: Preclinical
Molecular Formula: C35H39N7O5S
Molecular Weight: 669.81
Associated Items:
ID: ALA5284532
Max Phase: Preclinical
Molecular Formula: C35H39N7O5S
Molecular Weight: 669.81
Associated Items:
Canonical SMILES: NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CSCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccccc1
Standard InChI: InChI=1S/C35H39N7O5S/c36-26(15-22-9-3-1-4-10-22)32(44)41-29(16-23-11-5-2-6-12-23)35(47)42-21-48-20-30(42)34(46)40-28(33(45)39-19-31(37)43)17-24-18-38-27-14-8-7-13-25(24)27/h1-14,18,26,28-30,38H,15-17,19-21,36H2,(H2,37,43)(H,39,45)(H,40,46)(H,41,44)/t26-,28-,29-,30-/m0/s1
Standard InChI Key: XMLNBLQJGFSMDT-SYKYGTKKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 669.81 | Molecular Weight (Monoisotopic): 669.2733 | AlogP: 1.00 | #Rotatable Bonds: 14 |
Polar Surface Area: 192.51 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.97 | CX Basic pKa: 7.71 | CX LogP: 1.10 | CX LogD: 0.62 |
Aromatic Rings: 4 | Heavy Atoms: 48 | QED Weighted: 0.12 | Np Likeness Score: -0.42 |
1. Kashif Khan R, Meanwell NA, Hager HH.. (2022) Pseudoprolines as stereoelectronically tunable proline isosteres., 75 [PMID:36096342] [10.1016/j.bmcl.2022.128983] |
Source(1):